REDDING, Calif. , May 29, 2024 /PRNewswire/ -- According to a new market research report titled, " High Throughput Screening Market by Technology (Cell-based Assays [2D, 3D], Label-free, Lab-on-chip), Offering (Reagents, Liquid Handling, Readers, Sample Prep), Application (Target Identification, Toxicology, Stem Cell), End User–Global Forecast to 2031 ", published by Meticulous Research ® , the high throughput screening market is projected to reach $47.41 billion by 2031 at a CAGR of 10.
1% from 2024 to 2031. Download Sample Report Now- https://www.meticulousresearch.
com/download-sample-report/cp_id=3206 High throughput screening (HTS) is a technique employed in drug discovery to quickly test large numbers of compounds for their potential as therapeutic agents. This methodology is mainly used to screen and analyze millions of compounds in a short period, improving the probability of discovering promising small-molecule drug candidates. Recently, ultra-high throughput screening (UHTP) has advanced the drug discovery process and enabled drug developers to increase the screening load.
The UHTP method relies on advancements in robotics and automation. Automation and robotics have increased cost-effectiveness, efficiency, and productivity in the ultra-high throughput screening process. Automated systems, such as robotic arms and conveyor belts, can perform repetitive tasks with higher speed and accuracy, reducing labor costs and increasing the output of the screening process.
HT.
